In line with these effects, combined GIPR/GLP1R agonism strongly lowered the score for macrovascular steatosis as explained by both GIPR and GLP1R agonism in the two-way ANOVA (Fig. 3F and G). The gene discussed is GIPR; the disease is steatosis.